MA Optometry Jurisprudence cheat sheet

The Massachusetts Board of Registration in Optometry consists of 5 members appointed by the Governor: 4 licensed optometrists and 1 public member who is not an optometrist and has no financial interest in optometric practice.

Board members serve 5-year terms; a member may serve no more than two consecutive terms, and vacancies are filled by gubernatorial appointment for the unexpired portion of the term.

The Board's statutory authority derives from M.G.L. c. 112, §§ 66 through 73 (optometry) and c. 13, § 16, which creates the Board; the Board adopts regulations at 246 CMR 1.00–2.00.

Licensure requires: age 18+, good moral character, graduation from an accredited optometry school (ACOE), passage of NBEO Parts I, II, and III (or successor examination), and passage of the Massachusetts jurisprudence examination.

The Board may issue licenses by reciprocity/endorsement to applicants licensed in another jurisdiction with equivalent standards, subject to Board review and the jurisprudence examination.

License renewal is biennial, expiring in even-numbered years on the licensee's birthday; a late renewal fee and possibly a lapsed-license penalty apply, and practicing on a lapsed license is unlicensed practice.

The Board may issue a limited license (e.g., for faculty or postgraduate training) with defined supervision and duration; limited licensees must practice under the scope and supervision stated in the license.

Unlicensed practice of optometry, or aiding and abetting it, is a violation subject to Board discipline and criminal penalties under M.G.L. c. 112, § 73; the Board may seek injunctive relief.

The Board has authority to investigate complaints, subpoena records, hold adjudicatory hearings under M.G.L. c. 30A, and impose sanctions including reprimand, suspension, revocation, and civil fines.

Massachusetts optometrists are licensed to examine, diagnose, treat, and manage conditions of the human eye and visual system, including refractive errors and ocular disease within the scope defined by M.G.L. c. 112, § 66 and 246 CMR.

TPA (therapeutic pharmaceutical agents) authority permits prescribing topical and oral medications for ocular conditions; TPA certification requires completion of Board-approved pharmacology education and passage of the TMOD (Treatment and Management of Ocular Disease) examination.

TPA+GC (glaucoma certification) is a separate credential allowing diagnosis and treatment of glaucoma; it requires additional Board-approved education and passage of the glaucoma examination (e.g., NBEO or equivalent).

Glaucoma management under TPA+GC includes prescribing topical hypotensive agents, monitoring IOP, optic nerve, and visual fields, and co-managing surgical cases; laser and incisional surgery remain outside optometric scope.

Optometrists may not perform surgery, including laser procedures, and may not prescribe Schedule II controlled substances; Schedule III–VI prescribing is permitted only when consistent with TPA authority.

Prescriptions must include the prescriber's name, license number, DEA number where applicable, date, drug, strength, quantity, directions, and refill authorization; oral prescriptions must be documented in the record.

Optometrists must maintain a written or electronic record of all medications prescribed and dispensed, and must report adverse events consistent with Board guidance.

TPA and TPA+GC certification must be maintained through continuing education; failure to maintain pharmacology CE may result in loss of prescriptive authority.

Optometrists must refer to an ophthalmologist when a condition exceeds scope, including intraocular surgery, retinal surgery, and conditions requiring Schedule II analgesia.

Massachusetts requires 30 hours of continuing education per biennial renewal cycle, including at least 2 hours in ethics and 2 hours in infection control (or as otherwise specified by Board rule).

TPA-certified optometrists must complete additional pharmacology/therapeutics CE hours per cycle (commonly 16 hours) to maintain prescriptive authority; TPA+GC holders must complete glaucoma-specific CE.

CE must be from Board-approved providers (e.g., ACOE-accredited, COPE-approved, or state association programs); self-study and journal clubs are limited unless Board-approved.

At least 1 hour of CE in opioid prescribing/risk management may be required for prescribers under state law; verify current Board rule for the exact hour and cycle.

CE hours must be documented with certificates showing provider, title, date, hours, and topic; records must be retained for at least 4 years and produced on Board audit.

New licensees must complete jurisprudence and, where applicable, pharmacology training before TPA/TPA+GC certification is granted; certification is not automatic with licensure.

Failure to complete required CE by renewal may result in non-renewal, probation, or a Board order to complete deficient hours plus a fine.

CE credit for teaching, publications, or board service is limited and must be pre-approved by the Board; excess hours may not be carried over unless the Board rule permits.

Grounds for discipline under M.G.L. c. 112, § 71 include fraud, deceit, negligence, incompetence, unprofessional conduct, practicing beyond scope, and violation of Board rules.

The Board may receive complaints from patients, other licensees, insurers, or on its own motion; complaints are screened, investigated, and may proceed to an Order to Show Cause and adjudicatory hearing.

Licensees must respond to Board subpoenas and inquiries within the stated time; failure to cooperate is itself a disciplinary violation.

Sanctions range from reprimand and probation to suspension, revocation, and civil fines; the Board may also require remedial education, monitoring, or practice restrictions.

Mandatory reporting: licensees must report certain adverse events and any suspected impairment or misconduct by colleagues as required by law; patient confidentiality is governed by HIPAA and state law.

Informed consent, accurate records, and non-abandonment are core standards; abandoning a patient without notice and referral is unprofessional conduct.

Discipline is reported to national databases (e.g., NPDB) and may trigger reciprocal action in other states; licensees must self-report certain actions to the Board.

A licensee may appeal a final Board decision under M.G.L. c. 30A, § 14, to the Superior Court within 30 days of the final order.

246 CMR 1.00–2.00 sets out licensure, renewal, CE, and practice standards; the Board publishes policy statements and advisories that supplement the regulations.

Massachusetts requires optometrists to display their license or a copy at the practice location and to include the license number on prescriptions, reports, and advertising.

Advertising must be truthful, not misleading, and must not claim superiority or guarantee outcomes; testimonials and price advertising are permitted if not deceptive.

Infection control standards require compliance with CDC and OSHA bloodborne pathogen rules, including hand hygiene, disinfection of tonometer tips, and safe injection practices where applicable.

Recordkeeping: patient records must be retained for at least 7 years (longer for minors) and include history, findings, diagnosis, treatment, and informed consent.

Telehealth is permitted within scope, but the optometrist must establish a valid practitioner-patient relationship, verify identity, maintain records, and follow the same standard of care as in person.

Prescribing controlled substances requires a valid DEA registration and compliance with Massachusetts PMP (prescription monitoring program) query and reporting requirements.

Optometrists must report changes of address, name, or practice status to the Board within the time specified (commonly 30 days) and must not practice under a false or assumed name without registration.